The main draw of SmartCells is its SmartInsulin, which is currently in preclinical development and may not be on the market for a while, the news provider said.
READ MORE JANUVIA LEGAL NEWS
Rather than constantly measuring their glucose levels, diabetics using the drug can just inject it once a day and allow SmartInsulin to release it when it becomes necessary, the news source said.
The Smart technology could reportedly also extend further than insulin and may potentially be used to sense any molecule before releasing the necessary drug.
According to the National Center for Biotechnology Information, Merck's current diabetes drug, Januvia, can cause a range of side effects including sore throat, headache, loss of appetite, and nausea and vomiting.